Search Results - "Whelchel, John"

Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data by Lorber, Marc I, Ponticelli, Claudio, Whelchel, John, Mayer, Hartmut W, Kovarik, John, Li, Yulan, Schmidli, Heinz

“…:  The aims of the current study were to determine whether therapeutic drug monitoring (TDM) might benefit kidney transplant recipients receiving everolimus,…”
Get full text

Microchimerism and rejection in clinical transplantation by Elwood, E T, Larsen, C P, Maurer, D H, Routenberg, K L, Neylan, J F, Whelchel, J D, O'Brien, D P, Pearson, T C

“…Haemopoietic microchimerism has been identified in recipients of solid-organ transplants and is thought by some to be critical for the development and…”
Get more information

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection

Get full text

Remission of essential hypertension after renal transplantation by Curtis, J J, Luke, R G, Dustan, H P, Kashgarian, M, Whelchel, J D, Jones, P, Diethelm, A G

“…Six patients in whom "essential hypertension" led to nephrosclerosis and kidney failure received kidney transplants from normotensive donors. After an average…”
Get more information

Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension by Curtis, J J, Luke, R G, Whelchel, J D, Diethelm, A G, Jones, P, Dustan, H P

Get more information

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies by Vitko, Stefan, Tedesco, Helio, Eris, Josette, Pascual, Julio, Whelchel, John, Magee, John C., Campbell, Scott, Civati, Giovanni, Bourbigot, Bernard, Filho, Gentil Alves, Leone, John, Garcia, Valter Duro, Rigotti, Paolo, Esmeraldo, Ronaldo, Cambi, Vincenzo, Haas, Tomas, Jappe, Annette, Bernhardt, Peter, Geissler, Johanna, Cretin, Nathalie

“…Two prospective, randomized studies evaluated everolimus 1.5 vs. 3 mg/day with steroids and low‐exposure cyclosporine (CsA) (C2 monitoring) in de novo renal…”
Get full text

12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients by Tedesco-Silva, Jr, Helio, Vitko, Stefan, Pascual, Julio, Eris, Josette, Magee, John C, Whelchel, John, Civati, Giovanni, Campbell, Scott, Alves-Filho, Gentil, Bourbigot, Bernard, Garcia, Valter Duro, Leone, John, Esmeraldo, Ronaldo, Rigotti, Paolo, Cambi, Vincenzo, Haas, Tomas

“…The proliferation signal inhibitor everolimus (Certican), has demonstrated efficacy with full-dose cyclosporine (CsA) (Neoral). Two multicenter randomized…”
Get more information

Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients by Pescovitz, Mark D., Vincenti, Flavio, Hart, Marquis, Melton, Larry, Whelchel, John, Mulgaonkar, Shamkant, McKay, Diane, Leung, Mimi, Calleja, Elizabeth, Bouw, M. René

“…Aims To compare the pharmacokinetics of mycophenolic acid (MPA) and its metabolite (MPAG) when mycophenolate mofetil (MMF) is administered in combination with…”
Get full text

Ureteral obstruction due to calculi in the early postoperative period in renal cadaveric transplantation: a case report and discussion of ureteral obstruction in the renal transplant patient by Heron, S P, O'Brien, 3rd, D P, Whelchel, J D, Neylan, J F

“…We report a case of obstruction secondary to multiple ureteral calculi on postoperative day 3 after cadaveric renal transplantation. Treatment consisted of…”
Get more information

Pharmacology, Tolerance, and Antiviral Activity of Vidarabine Monophosphate in Humans by Whitley, R J, Tucker, B C, Kinkel, A W, Barton, N H, Pass, R F, Whelchel, J D, Cobbs, C G, Diethelm, A G, Buchanan, R A

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Ten-year follow-up in patients with combined heart and kidney transplantation by Trachiotis, Gregory D., Vega, J.David, Johnston, Thomas S, Berg, Alex, Whelchel, John, Smith, Andrew L, Lutz, Jerry, Kanter, Kirk R

“…Combined heart and kidney transplantation has been documented, although data regarding immunosuppression, rejection episodes, and graft or patient survival…”
Get full text

Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with cirolimus or ciclosporin in renal transplant patients by Pescovitz, Mark D, Vincenti, Flavio, Hart, Marquis, Melton, Larry, Whelchel, John, Mulgaonkar, Shamkant, McKay, Diane, Leung, Mimi, Calleja, Elizabeth, Bouw, M René

Get full text

Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients by Cibrik, Diane, Meier-Kriesche, Herwig-Ulf, Bresnahan, Barbara, Wu, You Min, Klintmalm, Goran, Kew, Clifton E., Kuo, Paul C, Whelchel, John, Cohen, David, Baliga, Prabakar, Akalin, Enver, Benedetti, Enrico, Wright, Francis, Lieberman, Bonnie, Ulbricht, Bettina, Jensik, Stephen

“…:  Background:  Cyclosporine exposure, as estimated by the area under the curve (AUC), predicts outcomes in renal transplantation. Cyclosporine concentration…”
Get full text

Renal function with cyclosporine C 2 monitoring, enteric‐coated mycophenolate sodium and basiliximab: a 12‐month randomized trial in renal transplant recipients by Cibrik, Diane, Meier‐Kriesche, Herwig‐Ulf, Bresnahan, Barbara, Wu, You Min, Klintmalm, Goran, Kew, Clifton E., Kuo, Paul C, Whelchel, John, Cohen, David, Baliga, Prabakar, Akalin, Enver, Benedetti, Enrico, Wright, Francis, Lieberman, Bonnie, Ulbricht, Bettina, Jensik, Stephen

“…Background:  Cyclosporine exposure, as estimated by the area under the curve (AUC), predicts outcomes in renal transplantation. Cyclosporine concentration at…”
Get full text

Captopril and renal insufficiency

Get more information

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group by Woodle, E S, Thistlethwaite, J R, Gordon, J H, Laskow, D, Deierhoi, M H, Burdick, J, Pirsch, J D, Sollinger, H, Vincenti, F, Burrows, L, Schwartz, B, Danovitch, G M, Wilkinson, A H, Shaffer, D, Simpson, M A, Freeman, R B, Rohrer, R J, Mendez, R, Aswad, S, Munn, S R, Wiesner, R H, Delmonico, F L, Neylan, J, Whelchel, J

“…A multicenter trial was conducted to evaluate the efficacy and safety of tacrolimus in the treatment of refractory renal allograft rejection. Renal transplant…”
Get full text

Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients by Rodey, G E, Neylan, J F, Whelchel, J D, Revels, K W, Bray, R A

“…Sera obtained sequentially from 419 patients awaiting solid organ transplantation were screened and analyzed for HLA class I epitope specificity. Antibodies…”
Get more information

Remission of essential hypertension after renal transplantation. Commentaries by CURTIS, John J, LUKE, Robert G, DUSTAN, Harriet P, KASHGARIAN, Michael, WHELCHEL, John D, JONES, Patricia, DIETHELM, Arnold G, RITZ, Eberhard

Get full text

Drainage of the exocrine pancreas in clinical transplantation: comparison of bladder versus enteric drainage in a consecutive series by Pearson, T C, Santamaria, P J, Routenberg, K L, O'Brien, D P, Whelchel, J D, Neylan, J F, Larsen, C P

“…The purpose of this study was to define the incidence of urologic and metabolic complications after simultaneous kidney/pancreas transplantation (SKPT) with…”
Get more information

Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation by Sands, J M, Neylan, J F, Olson, R A, O'Brien, D P, Whelchel, J D, Mitch, W E

“…Atrial natriuretic factor (ANF) ameliorates renal damage in animal models of acute ischemic renal failure. Consequently, ANF could blunt acute tubular necrosis…”
Get full text